Paid sickle cell disease research studies
Be first in line for our next sickle cell disease study , no open spots today, but we launch new ones every few weeks.
No open sickle cell disease studies right now
Register your interest below , we'll email you as soon as one opens.
Be first in line , it's two minutes.
We typically launch new sickle cell disease studies every few weeks. Registered participants hear about them before they go live on the public site.
Sickle cell disease research , frequently asked questions
Are MediTalk sickle cell disease studies paid?
Yes. Every MediTalk research study , including those focused on sickle cell disease , offers compensation for your time. Payment varies by study format and length, and is shown on each study's listing before you express interest.
Who can take part in sickle cell disease research on MediTalk?
Anyone diagnosed with sickle cell disease (and in some studies, family members or caregivers of someone with sickle cell disease) can register their interest. Each study has its own eligibility criteria (age, country, treatment history) shown on its listing , so you only spend time on studies you're actually a fit for.
How does a sickle cell disease study work in practice?
Most MediTalk sickle cell disease studies are remote and run on Zoom or a similar video platform , one-to-one interviews, focus groups or online surveys. Time commitment is shown on each listing (typically 30-90 minutes). You only need a quiet space, a webcam and a stable internet connection.
Is my sickle cell disease information kept private?
Yes. MediTalk is a UK-registered healthcare market-research platform run by Medicys Ltd, and all submissions are handled under UK GDPR. Your name and contact details are never shared with study sponsors , only de-identified research insights are reported back.
What if there are no open sickle cell disease studies right now?
Register your interest anyway , registration takes about two minutes, and you'll be the first to hear when a new sickle cell disease study opens. We typically launch new studies every few weeks across many conditions.
Ready to share your sickle cell disease experience?
Two minutes to register. We'll only contact you about studies that match what you've told us , no spam, no third-party sharing.